Product
Anti-Human Thymocyte Immunoglobulin
Aliases
Anti-Human Thymocyte Immunoglobulin, Rabbit
2 clinical trials
3 indications
Indication
Diabetes MellitusIndication
Type 1Indication
Aplastic AnemiaClinical trial
MELD-ATG: Phase II, Dose Ranging, Efficacy Study of Anti-thymocyte Globulin (ATG) Within 6 Weeks of Diagnosis of Type 1 Diabetes (T1D)Status: Active (not recruiting), Estimated PCD: 2024-12-01
Clinical trial
Ciclosporin + Antithymocyte Immunoglobulin + Avatrombpag Versus Ciclosporin + Avatrombpag for the Treatment of Severe Aplastic Anemia in the ElderlyStatus: Not yet recruiting, Estimated PCD: 2025-10-01